Kids with COVID-19 often have no symptoms; smoking linked to vaccine response

By Nancy Lapid

(Reuters) – Here is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

Asymptomatic COVID-19 very common

Roughly one-third of people with COVID-19 have no symptoms, according to a review of data from more than 350 studies published through April 2021. Asymptomatic infections were more common in children than in the elderly or in people without preexisting medical conditions, said Pratha Sah of Yale School of Public Health, who led the analysis published on Tuesday in PNAS. Her team estimates that 46.7% of infected children have no symptoms, she said. “This is especially concerning because settings with close, extensive contact among large groups of younger individuals are particularly susceptible to super spreader events of COVID-19, which may go undetected” if school authorities only watch for symptoms. Senior author Alison Galvani, also of the Yale School of Public Health, noted that asymptomatic individuals can still pass the virus to others, which makes mask wearing important as schools reopen.

Weight-loss surgery tied to better COVID-19 outcomes

Surgery for obesity may have a protective effect against poor outcomes from COVID-19, data from one New York City hospital suggest. Doctors there studied 620 patients with COVID-19, including 130 who had previously undergone so-called bariatric operations to treat their obesity, and a control group of 496 patients with obesity of similar age and gender who were eligible for these surgeries but had not undergone them. Compared to the control group, the patients who had undergone the bariatric procedures – gastric bypass, gastric banding, or sleeve gastrectomy – were less likely to be hospitalized, less likely to need a mechanical ventilator for breathing, and less likely to die in the hospital, even though many of them were still obese. They were also released from hospital faster, and those who were admitted to the ICU spent fewer days there, according to a report published on Sunday in Surgery for Obesity and Related Diseases. “Patients with obesity have been disproportionately impacted by COVID-19 with a higher risk of severe disease and death,” the authors pointed out. They added that while the study cannot prove that bariatric surgery caused better outcomes, the results suggest it might be “a protective factor against severe COVID-19 … in the high-risk population with obesity.”

Smoking may impair mRNA vaccine response

Current smokers may be at risk for lower immune responses to some COVID-19 vaccines, Japanese researchers say, though more research is needed before firm conclusions can be drawn. In a preliminary study of 378 healthcare workers, ages 32 to 54, the researchers analyzed levels of protective antibodies induced by the mRNA vaccine from Pfizer and BioNTech, using blood samples obtained roughly three months after the second dose. As has been found in previous studies, older participants had lower antibody levels. After taking age into account, the only risk factors for lower antibody levels were male sex and smoking – and the gender difference might be because smoking rates were twice as high in men as in women, the researchers speculate. In a paper posted on Saturday on medRxiv ahead of peer review, they report that antibody levels were higher in former smokers than in current smokers, which “suggests smoking cessation will reduce the risk of a lower antibody titer.”

Microscopic lung damage may continue in ‘long COVID’

The persistent breathing issues that plague some COVID-19 survivors, known as “long COVID,” may be due to microscopic processes that continue to damage lungs even after the acute infection is over, new research suggests. The researchers studied blood and airway cells from 38 patients who still had breathing problems at least three months after they were discharged from hospital. Compared to healthy volunteers, the airways of these COVID-19 survivors had higher numbers of immune cells that defend against viruses but can also cause damage. They also had higher levels of proteins that are present when cell death and tissue repair are happening. The findings, which still need confirmation in larger studies, suggest some patients have ongoing disturbances in their immune cells and damage to cells that line the airways, even several months after their initial infection and discharge from hospital, said James Harker of Imperial College London, coauthor of a report published on medRxiv ahead of peer review. “In a small group of patients, we were able to show that the abnormalities may in fact resolve with more time,” Harker said.

(Reporting by Nancy Lapid; Editing by Tiffany Wu)

Trump’s son Barron tested positive for COVID-19, says Melania Trump

WASHINGTON (Reuters) – President Donald Trump’s 14-year-old son, Barron, tested positive for COVID-19 but exhibited no symptoms after both of his parents contracted the virus, first lady Melania Trump said on Wednesday.

“Luckily he is a strong teenager and exhibited no symptoms,” Melania Trump said in a statement. She said she and Barron had since tested negative for the virus.

Donald Trump told a rally in Des Moines, Iowa, that Barron “is just fine now” and said it was an example of why schools should reopen.

“I don’t even think he knew he had it, because they’re young and their immune systems are strong and they fight it off,” Trump said. “Get the kids back to school,” he said.

Melania Trump said her symptoms were “minimal” and that she hoped to resume her duties as first lady “as soon as I can.”

“I experienced body aches, a cough and headaches, and felt extremely tired most of the time,” she said.

“I chose to go a more natural route in terms of medicine, opting more for vitamins and healthy food,” Melania Trump said.

Donald Trump spent three nights in a military hospital after announcing on Oct. 2 that he and Melania had tested positive.

To treat the virus, he received an experimental dual antibody therapy developed by Regeneron Pharmaceuticals Inc and Gilead Sciences Inc’s antiviral remdesivir, as well as the steroid dexamethasone.

“In one way I was glad the three of us went through this at the same time so we could take care of one another and spend time together,” Melania Trump said.

(Reporting by Eric Beech; Editing by Leslie Adler and Peter Cooney)

Six coronavirus cases discovered in north Italy, hundreds to be tested

By Elisa Anzolin and Angelo Amante

MILAN (Reuters) – Six people have tested positive in Italy for coronavirus, the northern Lombardy region said on Friday, in the first known cases of local transmission of the potentially deadly illness in the country.

Officials told residents from three small towns some 60 km (40 miles) southeast of Italy’s financial capital Milan, to stay at home as doctors tested hundreds of people who might have come into contact with the six coronavirus sufferers.

None of the six were believed to have visited China, which is the epicentre of the virus, but the first infected patient, a 38-year-old man now in intensive care, fell ill after meeting a friend who had recently been to China.

That man has since tested negative to the contagious disease, but doctors were investigating whether he carried the virus and subsequently recovered without showing any symptoms, said regional councillor Giulio Gallera.

The pregnant wife of the initial patient and one of his friends were also infected, along with three other people who were admitted to hospital overnight suffering from pneumonia-like symptoms.

“We have called on the residents of Codogno, Castiglione d’Adda and Casalpusterlengo to stay at home as a precaution,” Gallera told a news conference.

Prime Minister Giuseppe Conte said there was compulsory quarantine in place for all who have been in contact with the infected patients, as local authorities continued to track down everyone they had come into contact with.

“Most of the contacts of those who tested positive for coronavirus have been identified and subjected to the necessary tests and measures,” the region said in a statement.

Prior to Friday, just three people had been confirmed in Italy to have the virus which emerged in the Chinese city of Wuhan late last year.

Two Chinese tourists who came from Wuhan tested positive in Rome in late January, while an Italian who returned from the Chinese city with a special flight repatriating some 56 nationals was hospitalized a week later.

China has had more than 75,400 cases of the coronavirus and 2,236 people have died, most in Hubei province and its capital Wuhan.

(Angelo Amante reported from Rome; Additional reporting by Francesco Guarascio in Brussels and Elvira Pollina in Milan; Editing by Crispian Balmer and Christina Fincher)